1285-P: Impact of Adding a GLP-1 Receptor Agonist to the Medication Regimen
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes"
DOI: 10.2337/db19-1285-p
Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are preferred injectable therapies for type 2 diabetes, but it is uncertain if advantages justify higher medication cost. This real-world, retrospective cohort study at eight ambulatory care sites evaluated… read more here.
Keywords: none; adding glp; medication; impact ... See more keywords